A dose reduction of Erleada may result in fewer skin-related side effects for men with advanced prostate cancer — but only for those with a smaller body size, research showed. A dose reduction of ...
The use of prostate-specific antigen (PSA) testing for prostate cancer screening remains the subject of scientific debate. Experts are unable to agree on how to balance the benefit of such testing ...
Three-dimensional ultrasound-based spectroscopic imaging for the detection of prostate cancer. Background: We previously reported that physical activity may reduce prostate cancer (CaP) risk among men ...
SALT LAKE CITY, Aug. 15, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN) a leader in genetic testing and precision medicine, today announced the integration of Absolute Risk Reduction ...
Elevating cardiorespiratory fitness may considerably lower the incidence of prostate cancer, according to new research that was published in the British Journal of Sports Medicine. The Swedish School ...
The magnitude of the reduction in prostate cancer deaths from population-based PSA screening is too small for a clinical and public health benefit. PSA screening of the general male population ...
The predictive value of HGPIN and ASAP for the subsequent diagnosis of prostate cancer in the Reduction by Dutasteride of Cancer Events (REDUCE) study. Background: REDUCE was a randomized, ...
A European study has demonstrated a sustained long-term reduction in prostate cancer mortality through prostate-specific antigen (PSA) screening. However, the findings also highlight the issue of ...
Observational data suggested that men with nonmetastatic prostate cancer lived longer if they followed a healthier lifestyle. A higher prostate cancer behavior score was associated with reductions in ...
A state-of-the-art laser prostate reduction operation is now being successfully delivered in the county as a day case procedure. HOLEP, or Holmium Laser Enucleation of the Prostate, is a minimally ...
A single invitation for a prostate-specific antigen (PSA) screening test results in a small but significant reduction in prostate cancer deaths, but also leads to overdiagnosis and missed early ...